• Mr. Mahadeo G. Dhote
• Mr. Rahul S. Mohan
• Dr. Rajendra M. Kawde
• Mr. Krishna U. Jagtap
• Mr. Krushna B. Moin

ABSTRACT:- The prevalence of Type-2 diabetes is an increasing global problem. Especially in developed countries and is reered as twin epidemics. Such as, Advanced treatment aprroches are needed.Tirzepatide developed by eli lily was under the brand name 'mounsaro' by the united states Food Drug administration (FDA)in may 2022. Tirzepatide, sold under the brand name mounjaro is medication. Used for the treatment of type-2 diabetes. Tirzepatide is given by the weakly subcutaneous injection (under the skin). Common side effects may include like (Nausea, vomiting ,diarrhea,Constipation, abdominal) discomfort and abdominal pain. The type -2 diabetes drug tirzepatide has been reported to induced weight loss in patients with diabetes.

KEYWORD:- tirzepatide, twincretin, short peptide, incretins, diabetes, obesity

"Tirzepatide:- To Improve Blood Sugar Control in Diabetes In Addition Of To Diet And Exercise", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 11, page no.c722-c730, November-2023, Available :http://www.jetir.org/papers/JETIR2311298.pdf

"Tirzepatide:- To Improve Blood Sugar Control in Diabetes In Addition Of To Diet And Exercise", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 11, page no. ppc722-c730, November-2023, Available at : http://www.jetir.org/papers/JETIR2311298.pdf